Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Pagitane: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Pagitane - General Information

Pagitane is a drug used to reduce levels of acetylcholine to return a balance with dopamine in the treatment and management of Parkinson's disease.

 

Pharmacology of Pagitane

Pagitane is a central anticholenergic used in the treatment of the symptoms of Parkinson's disease. It is a drug used to reduce levels of acetylcholine. Acetylcholine is usually in balance with dopamine neurotransmitters, however lower levels of dopamine are present in the brain of patients suffering from Parkinson's disease. By lowering levels of acetylcholine, it is thought that this balance may be restored.

 

Additional information about Pagitane

Pagitane Indication

For treatment and management of Parkinson's disease.

Mechanism Of Action
Pagitane binds the muscarinic acetylcholine receptor M1, effectively inhibiting acetylcholine. This decrease in acetylcholine restores the normal dopamine-acetylcholine balance and relieves the symptoms of Parkinson's disease.
Generic Name
Cycrimine
Synonyms
Cycrimine hydrochloride
Drug Category
Antiparkinson Agents; Antidyskinetics
Drug Type
Small Molecule; Approved
Other Brand Names containing Cycrimine
Pagitane;
Protein Binding
14-21%
Chemical IUPAC Name
1-cyclopentyl-1-phenyl-3-piperidin-1-ylpropan-1-ol
Chemical Formula
C19H29NO
Organisms Affected
Humans and other mammals